Farmas USA

GILD y los precios

http://www.forbes.com/sites/johnlamattina/2016/12/08/gileads-ceo-apologetic-about-sovaldis-1000-per-pill-price-tag/#12437f937898

GILD en semanal ... martillo ?

actualizo el chart de HZNP en semanal

edito: abre premarket HZNP con 5k a 14.9

Why Donald Trump's Putative FDA Pick Could Scare Pharma

http://www.forbes.com/sites/matthewherper/2016/12/08/why-donald-trumps-putative-fda-pick-could-scare-pharma/#184d01d558a4

INSY

shares fall by nearly 9% after former executives are charged in a racketeering scheme.

http://www.fool.com/investing/2016/12/09/this-marijuana-companys-in-hot-water-with-the-doj.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2

BMY

pays $19.5M to settle off-label marketing charges.. read documents here
https://www.statnews.com/pharmalot/2016/12/08/bristol-myers-abilify-off-label/

ESRX

Los de Citron atacan a Express Scripts

http://www.cnbc.com/2016/12/08/someone-quickly-made-almost-3-million-off-of-a-short-sellers-tweet.html

HZNP

Mizuho downgraded Horizon Pharma to Neutral with target $14

UBS Maintains Buy rating, PT $23

ya sabemos, creo yo, a que vino el sell off de ultima hora ... ese downgrade de Mizuho a 14$ desde los 30$ ! casi nada! debieron filtrarlo

HZNP

BMO lowering target to $24 from $29. Maintain Outperform as valuation is compelling & solid growth from the existing portfolio.